Skip to main content

MoneyWorks4Me

Jenburkt Pharmaceuticals board to consider dividend

19 May 2016 Evaluate

Jenburkt Pharmaceuticals has informed that a Meeting of Board of Directors of the Company is scheduled to be held on May 30, 2016, to consider and take on record the audited results for the quarter / financial year ended on March 31, 2016; and to recommend Dividend, if any.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1897.80
Dr. Reddys Labs. 1375.85
Cipla 1414.80
Lupin 2016.50
Zydus Lifesciences 1203.65
View more..